URO-1, Inc. is a life sciences company dedicated to advancing the tools and workflows used in soft tissue biopsy diagnostics.
Prostate cancer is the most commonly diagnosed cancer in the UK. But screening is not universal, and charities are divided over whether it should be extended. What do those living with the disease ...
Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...
Wayne Earle's life was turned upside down when a small lump on his genitals led to a devastating diagnosis - and the loss of his penis.
As Liz Cantor’s beloved mum Becky lay in a small cottage hospice on the Sunshine Coast, her daughter asked: “If you could ...
Prostate cancer is one of the most common cancers affecting men around the world. It develops in the prostate, a small gland ...
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...
Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...
UK surgeons remotely removed a man’s prostate cancer from 1,500 miles away in the country’s first successful robot-assisted telesurgery.
Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research.
First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results